Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis

Published:2007-03 Issue:3 Volume:131 Page:897-899
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Collard Harold R.,Anstrom Kevin J.,Schwarz Marvin I.,Zisman David A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference16 articles.

1. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis;Bjoraker;Am J Respir Crit Care Med,1998

2. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis;Nicholson;Am J Respir Crit Care Med,2000

3. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease;Arcasoy;Am J Respir Crit Care Med,2003

4. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis;Lettieri;Chest,2006

5. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis;Nadrous;Chest,2005

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Hypertension in Interstitial Lung Disease;CHEST;2024-05

2. A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials;BMC Pulmonary Medicine;2024-01-27

3. Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future;Frontiers in Medicine;2024-01-17

4. Pulmonary Hypertension in Underrepresented Minorities: A Narrative Review;Journal of Clinical Medicine;2024-01-04

5. Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension;Pulmonary Circulation;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3